AB1279 Efficacious transition from reference product infliximab to the biosimilar in daily practice
Layegh, Z., Ruwaard, J., Hebing, R.C., L`Ami, M.J., van der Weele, W., Nurmohamed, M.T., Wolbink, G., Krieckaert, C.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
FRI0713-HPR The patients’ perspectives towards the provision of information during transition to a biosimilar
Kreuk, J., Twisk, A., Meilink, J., Alblas, R., van der Weele, W., Hebing, R.C., Ruwaard, J., l'Ami, M., Layegh, Z., Wolbink, G.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article